Immunospecific regression of methylcholanthrene fibrosarcoma with the use of neuraminidase.
D000276:Adjuvants, Immunologic; D000818:Animals; D001665:Binding Sites; D005354:Fibrosarcoma / Q000139:chemically induced / Q000276:immunology* / Q000628:therapy*; D007167:Immunotherapy; D008748:Methylcholanthrene; D051379:Mice; D009368:Neoplasm Transplantation; D009438:Neuraminic Acids / Q000494:pharmacology; D009439:Neuraminidase / Q000627:therapeutic use*; D012513:Sarcoma, Experimental / Q000139:chemically induced / Q000276:immunology* / Q000628:therapy*; D014181:Transplantation Immunology; D014733:Vibrio / Q000201:enzymology
D000276:Adjuvants, Immunologic; D009438:Neuraminic Acids; D008748:Methylcholanthrene; D009439:Neuraminidase